WO2008125295A3 - Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln - Google Patents

Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln Download PDF

Info

Publication number
WO2008125295A3
WO2008125295A3 PCT/EP2008/002883 EP2008002883W WO2008125295A3 WO 2008125295 A3 WO2008125295 A3 WO 2008125295A3 EP 2008002883 W EP2008002883 W EP 2008002883W WO 2008125295 A3 WO2008125295 A3 WO 2008125295A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
pharmaceuticals
receptor ligands
vanilloid receptor
novel vanilloid
Prior art date
Application number
PCT/EP2008/002883
Other languages
English (en)
French (fr)
Other versions
WO2008125295A2 (de
Inventor
Robert Frank
Gregor Bahrenberg
Thomas Christoph
Klaus Schiene
Vry Jean De
Derek John Saunders
Bernd Sundermann
Jeewoo Lee
Original Assignee
Gruenenthal Gmbh
Robert Frank
Gregor Bahrenberg
Thomas Christoph
Klaus Schiene
Vry Jean De
Derek John Saunders
Bernd Sundermann
Jeewoo Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh, Robert Frank, Gregor Bahrenberg, Thomas Christoph, Klaus Schiene, Vry Jean De, Derek John Saunders, Bernd Sundermann, Jeewoo Lee filed Critical Gruenenthal Gmbh
Priority to EP08748889A priority Critical patent/EP2150531A2/de
Publication of WO2008125295A2 publication Critical patent/WO2008125295A2/de
Publication of WO2008125295A3 publication Critical patent/WO2008125295A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die vorliegende Erfindung betrifft neue Vanilloid-Rezeptor-Liganden, Verfahren zu ihrer Herstellung, Arzneimittel enthaltend diese Verbindungen und die Verwendung dieser Verbindungen zur Herstellung von Arzneimitteln.
PCT/EP2008/002883 2007-04-13 2008-04-11 Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln WO2008125295A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08748889A EP2150531A2 (de) 2007-04-13 2008-04-11 Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007017879 2007-04-13
DE102007017879.6 2007-04-13

Publications (2)

Publication Number Publication Date
WO2008125295A2 WO2008125295A2 (de) 2008-10-23
WO2008125295A3 true WO2008125295A3 (de) 2009-02-05

Family

ID=39748516

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/002883 WO2008125295A2 (de) 2007-04-13 2008-04-11 Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln

Country Status (3)

Country Link
US (1) US8735426B2 (de)
EP (1) EP2150531A2 (de)
WO (1) WO2008125295A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2755206C1 (ru) 2020-05-20 2021-09-14 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Средство пролонгированного анальгетического действия и лекарственный препарат на его основе

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003084A1 (en) * 2003-07-02 2005-01-13 Grunenthal Gmbh 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same
WO2007045462A2 (de) * 2005-10-19 2007-04-26 Grünenthal GmbH Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3306909A (en) * 1964-05-05 1967-02-28 Mead Johnson & Co 3-carbamoyl-1,5-diphenyl-2,4-pyrrolidinediones
FR2060460A5 (de) * 1968-12-21 1971-06-18 Coll Antonio

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003084A1 (en) * 2003-07-02 2005-01-13 Grunenthal Gmbh 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same
WO2007045462A2 (de) * 2005-10-19 2007-04-26 Grünenthal GmbH Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln

Also Published As

Publication number Publication date
US8735426B2 (en) 2014-05-27
WO2008125295A2 (de) 2008-10-23
EP2150531A2 (de) 2010-02-10
US20080275044A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
WO2007045462A3 (de) Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln
WO2008125342A3 (de) Vanilloid-rezeptor-liganden und ihre verwendung zur herstellung von arzneimitteln
PL1888541T3 (pl) Związki benzo[d]izoksazol-3-iloaminy i ich zastosowanie jako ligandów receptora waniloidowego
WO2008132139A3 (en) New heterocyclic derivatives useful for the treatment of cns disorders
WO2008009415A3 (de) 4-heteroaryl-substituierte 1-aminocyclohexan-1- und cyclohexen-1-derivate mit wirkung auf das opiod rezeptor system
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2010127856A8 (en) Substituted phenylureas and phenylamides as vanilloid receptor ligands
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
EP2251038A4 (de) Feste dispersion, pharmazeutische zusammensetzungen damit und verfahren zu ihrer herstellung
WO2009156462A3 (en) Organic compounds
GB0508318D0 (en) Organic compounds
PL2146959T3 (pl) Ligandy receptora waniloidowego i ich zastosowanie do wytwarzania leków
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
ZA200907096B (en) Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
WO2008149345A3 (en) Tri-aryl compounds and compositions comprising the same
GB0508314D0 (en) Organic compounds
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
WO2008065282A3 (fr) Pyrazoles substituees, compositions les contenant, procede de fabrication et utilisation
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
WO2009086163A3 (en) Thiazolylidine urea and amide derivatives and methods of use thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2008748889

Country of ref document: EP